- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ARGX-110
Total 6939 results
-
OncoVerity, Inc.Janssen Research & Development, LLC; argenxCompleted
-
Helios Albert-Schweitzer-Klinik NortheimCompletedColorectal Polyps | Colorectal AdenomasGermany, Poland
-
argenxCompletedBioavailability StudyNetherlands
-
argenxCompleted
-
argenxQuintiles, Inc.CompletedPrimary Immune ThrombocytopeniaAustria, Belgium, France, Germany, Spain, Czechia, Hungary, Poland, Ukraine, United Kingdom
-
argenxActive, not recruitingPrimary Immune ThrombocytopeniaUnited States, Austria, Belgium, Bulgaria, Czechia, France, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation, Spain, Turkey, United Kingdom, Ukraine
-
argenxCompletedGeneralized Myasthenia GravisUnited States, Belgium, Canada, Czechia, Denmark, France, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation, Serbia, United Kingdom
-
argenxRecruitingARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function (VARVARA)Delayed Graft FunctionAustralia, Spain, Belgium, Portugal, Canada
-
argenxRecruitingMultifocal Motor Neuropathy (MMN)United Kingdom, Spain, United States, Italy, Netherlands, Germany, France, Belgium, Canada, Poland, Austria
-
argenxActive, not recruitingMultifocal Motor NeuropathyUnited States, France, Germany, Belgium, Italy, Netherlands, Canada, United Kingdom, Austria, Poland, Spain
-
argenxQuintiles, Inc.CompletedMyasthenia GravisItaly, United States, Belgium, Canada, Netherlands, Poland, Spain, Sweden
-
argenxRecruiting
-
argenxCompletedGeneralized Myasthenia GravisUnited States, Belgium, Canada, Czechia, Denmark, France, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation, Serbia
-
argenxApproved for marketingGeneralized Myasthenia GravisUnited States
-
argenxCompleted
-
argenxWithdrawnPrimary Immune Thrombocytopenia (ITP)
-
argenxCompletedPrimary Immune ThrombocytopeniaUnited States, Austria, Belgium, Bulgaria, Czechia, France, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
argenxActive, not recruitingChronic Inflammatory Demyelinating Polyneuropathy (CIDP)United States, Austria, Belgium, Bulgaria, China, Czechia, Denmark, France, Georgia, Germany, Israel, Italy, Japan, Netherlands, Poland, Russian Federation, Serbia, Spain, Ukraine, United Kingdom, Latvia, Romania, Taiwan, Turkey
-
argenxCompletedPemphigus Vulgaris | Pemphigus FoliaceusGermany, Hungary, Israel, Italy, Ukraine
-
OncoVerity, Inc.Janssen Research & Development, LLC; argenxCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteSwitzerland, France
-
argenxCompletedHealthy VolunteersNetherlands
-
argenxRecruitingPrimary Immune ThrombocytopeniaUnited States, Australia, Bulgaria, China, Georgia, Greece, Italy, Japan, Poland, Portugal, Romania, Russian Federation, Thailand, Turkey, Argentina, Chile, Ireland, Jordan, Tunisia, Korea, Republic of, Mexico, New Zealand, South Africa and more
-
Yonsei UniversityCompleted
-
argenxActive, not recruitingPrimary Immune ThrombocytopeniaUnited States, France, Georgia, Germany, Italy, Japan, Poland, Russian Federation, Spain, Turkey, United Kingdom, Argentina, Australia, Bulgaria, Chile, China, Denmark, Greece, Ireland, Israel, Jordan, Korea, Republic of, Mexico, New... and more
-
REGENXBIO Inc.Active, not recruitingHurler Syndrome | Hurler-Scheie Syndrome | Mucopolysaccharidosis Type I (MPS I)United States, Brazil, Israel
-
argenxNot yet recruitingMyositis | Dermatomyositis
-
Johnson & Johnson Vision Care, Inc.Completed
-
Janssen Research & Development, LLCargenxWithdrawnMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicUnited Kingdom, Switzerland, Italy, Germany, France, Spain, Australia, Turkey, Brazil, Russian Federation, Saudi Arabia
-
OncoVerity, Inc.Janssen Pharmaceutical K.K.; argenxCompleted
-
MetiMedi PharmaceuticalsUnknown
-
OncoVerity, Inc.Janssen Research & Development, LLC; argenxActive, not recruitingLeukemia, Myeloid, AcuteCanada, United States, Poland, Switzerland, Germany
-
Heat BiologicsCompletedA Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid TumorsAdvanced Solid TumorUnited States
-
Clinical Nutrition Research Centre, SingaporeCompletedSatiationSingapore
-
Hospital General Universitario ElcheUnknown
-
PegBio Co., Ltd.CovanceCompletedType 2 Diabetes Mellitus (T2DM)United States
-
TR TherapeuticsCompleted
-
National Cancer Institute (NCI)Terminated
-
Aeglea BiotherapeuticsCompletedAdvanced CancersUnited States
-
TR TherapeuticsCompleted
-
Wake Forest University Health SciencesMedtronicRecruitingHiatal Hernia | Esophagogastric Junction DistensibilityUnited States
-
Nocion TherapeuticsCompleted
-
Transposon Therapeutics, Inc.Active, not recruitingProgressive Supranuclear PalsyUnited States
-
Cancer Trials IrelandCompletedPain | Unspecified Adult Solid Tumor, Protocol Specific | Radiation Toxicity | Spinal Cord CompressionIreland
-
AEterna ZentarisCompletedDiagnosis of Adult Growth Hormone Deficiency (AGDH)United States
-
REGENXBIO Inc.RecruitingDuchenne Muscular DystrophyUnited States
-
AbbVieAbbVieRecruiting
-
Tang-Du HospitalUnknown
-
Aeglea BiotherapeuticsCompletedArginase I Deficiency | HyperargininemiaUnited States, Canada, United Kingdom, Portugal